Contribution: CanExport
Agartee Technology Inc
$45,500.00
Agartee's 24 hrs personalized health monitoring system expansion to UK, Germany and France
FY 2018-19 · 2018-10-22
Summary
The funding will be used to expand Agartee's 24 hours personalized patient monitoring service to UK, Germany and France. The first target disease is COPD (Chronic Obstructive Pulmonary Disease), 4th cause of death worldwide.
Department
Program
CanExport
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
824185599
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-10-22 | 2018-19 | $37,500.00 |
| 1 | 2018-10-22 | 2018-19 | $45,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 8,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois. La valeur totale des modifications est de 8 000 dollars.
Agreement End Date
2019-08-31
Agreement Number
915818
Agreement Start Date
2018-10-22
Agreement Title
Agartee's 24 hrs personalized health monitoring system expansion to UK, Germany and France
Agreement Title (French)
Extension du système de surveillance de la santé personnalisé 24 heures sur 24 d'Agartee au Royaume-Uni, en Allemagne et en France
Agreement Type
Contribution
Agreement Value
$45,500.00
Amendment Date
2019-07-18
Amendment Number
1
Coverage
CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises. | Les projets CanExport contribuent à la croissance et à la diversification des exportations des petites et moyennes entreprises canadiennes.
Description
The funding will be used to expand Agartee's 24 hours personalized patient monitoring service to UK, Germany and France. The first target disease is COPD (Chronic Obstructive Pulmonary Disease), 4th cause of death worldwide.
Description (French)
Le financement servira à étendre le service personnalisé de surveillance des patients 24 heures sur 24 d'Agartee au Royaume-Uni, en Allemagne et en France. La première maladie cible est la maladie pulmonaire obstructive chronique (MPOC), 4ème cause de décès dans le monde.
Expected Results
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Expected Results (French)
CanExport a pour objectif de fournir un soutien financier direct aux petites et moyennes entreprises qui cherchent à saisir de nouveaux débouchés à l’exportation, particulièrement dans les marchés émergents à forte croissance.
Federal Riding
Vancouver East
Federal Riding (French)
Vancouver-Est
Federal Riding Number
59035
NAICS Code
621610
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
CanExport
Program Name (French)
CanExport
Program Purpose
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Program Purpose (French)
CanExport a pour objectif de fournir un soutien financier direct aux petites et moyennes entreprises qui cherchent à saisir de nouveaux débouchés à l’exportation, particulièrement dans les marchés émergents à forte croissance.
Recipient Business Number
824185599
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Agartee Technology Inc
Recipient Postal Code
V5T 4T5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q3-915818
